Nektar Therapeutics

Company Snapshot
455 Mission Bay Boulevard South
San Francisco, CA 94158
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 137
Please select from the dropdown
Company Financials

2021
2022
2023
Gross Profit
$77,010,000
$70,420,000
$56,354,000
Operating Income
-$446,103,000
-$240,236,000
-$135,225,000
Net Income
-$523,837,000
-$368,198,000
-$276,056,000
2021
Gross Profit
$77,010,000
Operating Income
-$446,103,000
Net Income
-$523,837,000
2022
Gross Profit
$70,420,000
Operating Income
-$240,236,000
Net Income
-$368,198,000
2023
Gross Profit
$56,354,000
Operating Income
-$135,225,000
Net Income
-$276,056,000
The above data on Nektar Therapeutics came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Director, President and Chief Executive Officer
$2,114,951
$927,160
$93,465
$3,135,576
$3,135,576
Director, President and Chief Executive Officer
Chief Research and Development Officer
$1,104,479
$178,300
$490,585
$1,773,364
$1,773,364
Chief Research and Development Officer
Secretary, Senior Vice President and Chief Legal Officer
$847,800
$231,790
$20,878
$1,100,468
$1,100,468
Secretary, Senior Vice President and Chief Legal Officer
Interim Chief Financial Officer and Principal Accounting Officer
$0
$0
$376,300
$376,300
$376,300
Interim Chief Financial Officer and Principal Accounting Officer
Independent Director
$128,000
$42,220
$0
$170,220
$170,220
Independent Director
Nektar Therapeutics listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2023. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us